In the next six years, 8.5 million Americans will have Alzheimer’s disease. New research shows how exercise can help the ...

LEXINGTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VYGR), a biotechnology company dedicated to advancing ...

Different types of brain cells could age at different speeds, and that may help explain the development of Alzheimer's ...

“Since hundreds of mitochondrial proteins become insoluble both during aging and after expressing amyloid beta, we thought if ...

The hunt for stable, readily observable biomarkers in biofluids, such microRNAs, presents a chance to identify Alzheimer's ...

In mice with Alzheimer's, the course of menthol for a six-month-long period was enough to stop the cognitive abilities and ...

NA-901 is under clinical development by Biomed Industries and currently in Phase II for Alzheimer’s Disease. According to GlobalData, Phase II drugs for Alzheimer’s Disease have a 36% phase transition ...

Some people with signs of Alzheimer’s disease in their brains may not show any clinical symptoms while alive, according to a ...

Petaluma, California - Boomers Today, a podcast hosted by Frank Samson, CEO and Founder of Senior Care Authority, has ...

Bezisterim is under clinical development by BioVie and currently in Phase III for Alzheimer’s Disease. According to GlobalData, Phase III drugs for Alzheimer’s Disease have a 12% phase transition ...

(FOX 9) - The fight against Alzheimer's will get extra help this weekend from a rising country music star who knows all too ...

To date, approaches to treatments for Alzheimer’s disease have not addressed the contribution of protein insolubility as a general phenomenon, instead focusing on one or two insoluble proteins. Buck ...